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Depression is a devastating illness. 
It is the leading cause of disability 
worldwide, and it afflicts 6.7% 
of Americans every year ((World 
Health Organization [WHO], 
2012; National Institutes of Mental 
Health [NIMH], 2014). Worse, 
there is considerable evidence that 
traditional therapy—particularly 
drug therapy—is not particularly 
effective (Whitaker, 2010; Krystal, 
Sanacora, & Duman, 2013). The data 
from the STAR*D trials conducted 
by NIMH demonstrated that, among 
4,000 depressed patients given 
standard antidepressant drugs, only 
slightly more than one quarter of 
these patients achieved remission 
after 3 months (Krystal et al., 2013).
Researchers have begun 
investigating new avenues for 
treating depression, in large part 
because of the inadequacy of 
standard antidepressant treatment. 
Omega-3 supplementation, bright 
light exposure, and exercise all have 
a positive impact on depressive 
symptoms (Grosso et al., 2014; Even, 
Schroder, Friedman, & Rouillon, 
2008; Josefsson, Lindwall, & Archer, 
2014). The Therapeutic Lifestyle 
Change (TLC) program combines 
these approaches, finding that they 
are even more effective together 
than separately (Ilardi et al., 2012).
A major problem for the success 
of any treatment is participant 
adherence (Centers for Disease 
Control [CDC], 2013). The CDC 
estimates that roughly 50% of 
medications are not continued 
as prescribed (2013), and others 
studies suggest that adherence to 
non-medication regimes—such 
as exercise plans—is even worse 
(Robison & Rogers, 1994; Findorff, 
Wyman, & Gross, 2009). It seems 
that not following the doctor’s 
orders really makes a difference 
too. Research shows that adherence 
really matters for determining 
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patient outcomes across a wide 
variety of illnesses, with this 
relationship being strongest for 
chronic illness not treated with 
medication (DiMatteo, Giordani, 
Lepper, & Croghan, 2002).
Because depression is a chronic 
condition that the TLC program 
treats without medication, and 
because depression itself is known 
to be a risk factor for non-adherence 
(DiMatteo, Lepper, & Croghan, 
2000), this research seeks to answer 
two major questions about the 
impact of participant adherence on 
depressive symptoms:
1. Are participants more likely 
to adhere to one element of the 
treatment than another?
2. Does overall adherence to the 




The sample considered here consists 
of 95 TLC participants aged 18-
65 who met DSM-V criteria for 
clinical depression and did not 
have a comorbid DSM-V disorder. 
Trained clinicians administered a 
full Structured Clinical Interview for 
DSM Disorders (SCID) in order to 
confirm depression status. 
the Protocol
The TLC protocol consisted of 
fourteen 1.5 hour-long group 
sessions over the course of 14 weeks. 
Two co-therapists led the sessions, 
which were split roughly in two. 
For the first half of the session, one 
co-therapist led a discussion of 
adherence to the protocol, while 
for the second half, the other 
therapist trained participants in 
the protocol. Each week, a different 
core component of TLC was 
presented. The protocol consisted 
of six core components: omega-3 
supplementation, exercise, bright 
light exposure, anti-ruminative 
strategies, sleep habit improvement, 
and social support. Only adherence 
to omega-3 supplementation, 
exercise, and bright light exposure 
are considered in this presentation. 
This decision was made due to 
missing data and difficulty in 
calculating adherence indices for the 
other elements of the protocol. For 
the treatment elements examined in 
this work, the specific protocols were:
• Omega-3: one supplement 
containing 1000 mg EPA 
(eicosapentaenoic acid) and 500 
mg of DHA (docosahexaenoic acid) 
every day.
• Exercise: 30 minutes per day, three 
times a week.
• Bright Light: 10,000 lux for 30 
minutes per day, every day.
Measures
All participants completed our 
measures of depression and 
adherence at the beginning of each 
meeting. Depression was measured 
using the Beck Depression Index 
(BDI), and adherence was measured 
using weekly record forms. On the 
weekly record form, each treatment 
element was listed beneath each 
day of the week, and participants 
indicated with a yes or no whether 
or not they adhered to the given 
treatment element for each day listed.
Adherence Indices
In this study, adherence specifically 
refers to the percent of the time 
participants followed the TLC 
protocol for each treatment element. 
The adherence index for omega-3 
supplementation was calculated 
as the number of days out of 7 that 
participants took the supplement.  
For exercise, the adherence index 
was the percent of minutes out of 90 
that participants reported for that 
week. For bright light exposure, the 
adherence index was calculated as 
the percentage of days out of 7 that 
participants reported obtaining 
at least 30 minutes of bright light 
exposure. The mean of these weekly 
scores was taken over fourteen 
weeks to calculate a mean percent 
adherence score for each client on 
each individual element. Finally, an 
overall adherence score for each 
client was calculated by taking the 
mean of the individual element 
adherence scores.
results
Omega-3 supplementation had the 
highest mean percent adherence 
(M = 63.9%) followed by exercise 
(M = 54.5%), and then bright 
light exposure (M = 48.2%). We 
conducted a within-subjects analysis 
of variance (ANOVA) to test if mean 
adherence significantly differed 
among the three treatment elements. 
The overall model was significant, 
F(2, 188) = 51.65, p <.001.  Pairwise 
comparisons revealed that the mean 
adherence scores for each element 
significantly differed from one 
another, with all p-values <0.001. 
Figure 1 depicts the differences in 
mean percent adherence scores for 
each treatment element. 
The different types of adherence 
were highly correlated with one 
another (all r values > 0.8).  This 
finding suggested that all three 
adherence variables were measuring 
the same construct—overall 
adherence. For this reason, we first 
conducted a linear regression of 
final BDI score on overall adherence 
with pretreatment BDI as a covariate. 
The overall model was significant, 
with F (4, 90) = 6.245 and p-value: 
0.000176.  This regression found that 
Figure 1.  Mean Percent Adherence scores 
for Each treatment Element
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overall adherence had a statistically 
significant impact on reducing 
final BDI score, β = -0.31, p = 0.002. 
Our multiple R2 for this regression 
equaled 0.2172, signaling that overall 
adherence and pretreatment BDI 
score explained 21% of the variance 
in final BDI. Pretreatment BDI 
was added as a covariate in order 
to control for the fact that people 
who began the TLC program with 
lower BDI scores were more likely to 
complete treatment with lower BDI 
scores as well, even though the scores 
would have improved. See Table 1.
Separate regressions of final BDI 
score on participant mean weekly 
exercise, bright light, and omega-3 
adherence with pretreatment BDI 
as a covariate were also conducted. 
These results are displayed in Table 
2. Since adherence to one treatment 
element was highly correlated with 
adherence to the other treatment 
elements, a model containing all 
three types of adherence had high 
multicollinearity. In order to avoid 
this problem, we regressed BDI on 
each individual treatment element. 
These regressions show that 
adherence to each treatment element 
was predictive of outcome, but not 
uniquely predictive.
dISCuSSIOn
Previous studies have shown 
that adherence directly relates to 
outcome, particularly for illnesses 
that are chronic and not treated 
with medication (DiMatteo et 
al., 2002). The linear regression in 
Table I suggests that this finding 
extends to depression treated with 
the TLC protocol. Better adherence 
generally meant a better outcome for 
participants. 
Our finding that omega-3 
supplementation had the best 
adherence, followed by exercise, and 
then bright light exposure is fairly 
consistent with the broader literature 
on adherence.  To our knowledge, 
no previous work has been done to 
examine the rate of adherence to 
omega-3 supplementation, making it 
difficult to find a true reference point 
for our finding. However, taking an 
omega-3 supplement is the element 
of the protocol most like taking a 
medication or an antidepressant. A 
study by Lingam and Scott found 
that median non-adherence for 
antidepressant medications was 
53% (Lingam & Scott, 2002), while 
studies of medication adherence for 
chronic conditions in non-depressed 
individuals ranges from 43% to 
78% depending on the ailment 
being treated (Osterberg & Blaschke, 
2005). Our mean percent adherence 
for omega-3 supplementation of 
63.9% falls within this range. For 
exercise, our mean percent of 54.5% 
is similar to that found by studies of 
exercise adherence among specific 
populations, such as women and the 
elderly (Miranda et al., 2014; Findorff, 
Wyman, & Gross, 2009). However, 
to our knowledge, no studies 
rigorously examine adherence to an 
exercise regime among depressed 
patients. A study by Michalak et 
al. finds that average adherence 
to bright light exposure among 
patients diagnosed with seasonal 
affective disorder was 59.3%, which 
is substantially higher than our 
mean of 48.2% (2007). However, this 
study contained only 19 participants 
and was conducted over four weeks, 
limiting its generalizability. 
One factor influencing the pattern 
of adherence observed is the amount 
of time required to follow each 
element of the protocol. Conceivably, 
omega-3 supplementation had the 
best adherence because it required 
the least amount of time per week. 
Taking an omega-3 supplement 
takes less than 30 seconds each day. 
In contrast, following the exercise 
protocol required 90 minutes of 
participants’ time per week, while 
following the bright light protocol 
table 1: Linear regression of final 
bDI score on overall adherence with 
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required participants’ time every 
day—a total of 210 minutes per week. 
Thus, the element that required the 
most time had the poorest adherence, 
while the one that required the least 
time had the best. 
Another factor possibly 
influencing the pattern observed is 
American culture. In the U.S., we 
tend to prefer to treat sickness with 
medication rather than with lifestyle 
changes. So, it would follow that 
the element of the protocol that just 
requires taking a “pill” would have 
the best adherence. Americans also 
generally seek to avoid publicizing 
any psychiatric or psychological 
conditions. While one can easily 
take a pill without alerting a close 
friend or a loved one, it is much more 
difficult to begin a regular exercise 
regime or to spend 30 minutes each 
day obtaining bright light exposure 
without someone noticing. It is 
possible that we observed lower 
adherence for the exercise and 
bright light elements because some 
participants were attempting to hide 
their depression status from others.  
A major limitation of this 
research is that it relied exclusively 
on a weekly self-report measure of 
adherence. It is possible that from 
one week to the next participants did 
not accurately remember on which 
days they followed the protocol 
versus on which days they did not. It 
is also possible that participants may 
have intentionally misrepresented 
their adherence. Future research 
should include additional measures 
of adherence to improve these 
issues. For example, in order to verify 
exercise adherence, participants 
could be given a heart rate monitor 
that records the amount of time 
spent exercising. A clever method 
of verifying bright light adherence 
comes from the Michalak et al. study 
mentioned above. In this work, the 
light boxes given to clients were 
outfitted with hidden recording 
devices that monitored the amount 
of time the boxes were turned on. 
However, since TLC permits clients 
to obtain their bright light exposure 
from outside, we would still rely on a 
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